Trial intelligence / Profile preview

Butorphanol-based multimodal general anesthesia in laparoscopic gynecological surgery

ChiCTR2200062343Phase 4Not yet recruiting

Sponsor
Ningbo University Affiliated Hospital
Start
Jun 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of butorphanol and fentanyl in perioperative pain, Postoperative gastrointestinal dysfunction (POGD) and gynaecological conditions (2 arms), sponsored by Ningbo University Affiliated Hospital. Primary endpoint: Postoperative exhaust time. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

butorphanolfentanyl
03

Conditions

perioperative painPostoperative gastrointestinal dysfunction (POGD)gynaecological conditions

Beyond the preview

Go deeper on ChiCTR2200062343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call